Home Blog Page 1955

Jungbunzlauer Tricalcium Citrate Excipient Demonstrates Outstanding Results in Direct Compression Study

– New research confirms Jungbunzlauer’s TCC TB supports efficient, high-quality tablet manufacturing across challenging pharmaceutical and nutraceutical applications –

BASEL, Switzerland, Oct. 29, 2025 /PRNewswire/ — Jungbunzlauer, a global leader in high-quality, sustainable ingredients, and Professor Karl Wagner from the University of Bonn, announce the results of new research confirming Jungbunzlauer’s tricalcium citrate (TCC TB) sets a new standard for direct compression in pharmaceutical and nutraceutical tablet manufacturing.

Young woman swallowing a small pill
Young woman swallowing a small pill

“This collaboration with Professor Wagner and his workgroup from the Department of Pharmaceutical Technology and Biopharmaceutics at the University of Bonn underscores our commitment to rigorous science, innovation and product excellence,” said Markus Gerhart, Senior Director Category Lead Minerals & Solutions at Jungbunzlauer. “Through validated research, we’re proud to demonstrate that our TCC TB delivers reliable performance in direct compression, helping our customers achieve efficiency, quality, and confidence.”

Direct compression is increasingly favoured for its efficiency and suitability for sensitive ingredients, but it demands excipients with exceptional flow and compactibility. The study results confirm Jungbunzlauer’s TCC TB delivers excellent flowability, robust tablet strength at low compression force, and rapid disintegration, even for challenging formulations such as minitablets, moisture-sensitive APIs, and botanical actives.

Produced by complete neutralisation of citric acid with a high purity calcium source, TCC TB is certified vegan, allergen- and GMO-free, and meets USP, FCC, and EU standards.

The new findings will be presented at CPHI Global, Messe Frankfurt (Hall 8, Booth Q55) from 28–30 October 2025. Attendees are invited to discuss the data with Jungbunzlauer and explore how TCC TB can naturally support your next formulation challenge. 

About Jungbunzlauer

Jungbunzlauer is a leading producer of high-quality, sustainable ingredients from natural sources, serving industries from food and beverage, to nutrition, health, home and personal care, among others. Leading the way in developing naturally better ingredients that enhance everyday life, we are a trusted partner offering a diverse portfolio of texturants, acidulants, sweeteners, minerals, and tailored solutions to meet our customers’ evolving needs.

Headquartered in Basel, Switzerland, with state-of-the-art facilities including large-scale fermentation operations across Europe and North America, we proudly serve more than 130 countries worldwide. Founded more than 150 years ago, Jungbunzlauer has grown into a CHF 1.3 billion company, driven by nearly 1,400 dedicated colleagues committed to a healthier, more sustainable future. Learn more at http://www.jungbunzlauer.com

I-MAB (Nasdaq: IMAB) Transitions to NovaBridge Biosciences (Nasdaq: NBP) with Trading Effective October 30, 2025 New Brand and Logo to Reflect Strategic Transformation to a Global Biotech Platform

  • New corporate brand reflects strategic transformation to a global biotech platform accelerating access to innovative medicines for patients worldwide
  • Strategy centers on broadening access to global capital and innovation through a planned Hong Kong initial public offering (IPO), and holding dual listings on Nasdaq and Hong Kong Stock Exchange (HKEX)
  • Consistent with the new hub-and-spoke business model, the Company has formed a new subsidiary, Visara, Inc. (Visara), which acquired VIS-101, a novel bifunctional biologic targeting VEGF-A/ANG2 that could potentially provide more effective and durable treatment than the current standard of care for patients with wet AMD and DME
  • Company core asset, givastomig, a potential best-in-class Claudin 18.2 X 4-1BB bispecific antibody, continues to advance under previously announced investment plans

ROCKVILLE, Md., Oct. 29, 2025 /PRNewswire/ — NovaBridge Biosciences (NovaBridge or the Company) today announced that it has changed its corporate name from I-Mab to NovaBridge Biosciences. The change was overwhelmingly approved by shareholders at the Company’s Extraordinary General Meeting held on October 24, 2025, and by the Company’s Board of Directors. The Company’s American Depositary Shares (ADSs) will trade on Nasdaq under the new name and a new ticker symbol, “NBP”, effective at the opening of trading on October 30, 2025, replacing its current symbol “IMAB” (Nasdaq: IMAB).

The new corporate brand, including a new website (www.novabridge.com), marks an important step in the Company’s strategic transformation to a global biotechnology platform company committed to accelerating access to innovative medicines for patients worldwide.

In connection with the name change and ticker symbol change, no action is required from current shareholders and the Company’s CUSIP number will remain the same. Historical trading data of the Company’s ADSs prior to October 30, 2025 may not yet be available on certain third-party websites and apps when searching for “NovaBridge Biosciences” and/or “NBP”, in which case such data may temporarily be found under “I-MAB” and/or “IMAB”.

Overview of the NovaBridge Biosciences Logo – The connected molecules form the letter “N”, embodying our collaborative effort with partners to shape a healthier future, with an open circle to symbolize a spirit of continuous innovation and exploration. 

“Our new corporate branding successfully conveys the key elements of our new strategy, bridging collaboration, translational science, and execution to rapidly progress transformative therapies and strategically create significant value for patients and investors,” said Mr. Fu Wei, Executive Chairman of NovaBridge. “Our proposed dual listing on both Nasdaq and HKEX, a key element of our global growth strategy, will enable us to broaden and diversify our investor base, and enhance trading liquidity and access to capital, while strengthening our presence with key stakeholders in the rapidly growing Asian market.”

“NovaBridge’s new brand identity successfully aligns with our strategic transition to a global biotech platform. The recent presentation of encouraging updated Phase 1 monotherapy data at the Triple Meeting[1] for givastomig, a potential best-in-class Claudin 18.2-directed therapy for gastric cancers, and the formation of our new subsidiary, Visara, and its recent acquisition of VIS-101, a second-in-class potentially best-in-class bifunctional VEGF-A/ANG2 targeted biologic, provide positive validation of our new strategy. We continue to progress givastomig towards a global randomized Phase 2 study, expected to achieve enrollment of the first patient in Q1 2026,” said Sean Fu, PhD, Chief Executive Officer of NovaBridge. “We are pleased by the positive momentum from our new strategy, accented by our new corporate brand, and are optimistic that our global biotech platform will enable us to realize the full potential of innovative medicines and create value for patients and investors.”

The NovaBridge Business Model and Pipeline

The Company intends to partner with leading innovators to identify and accelerate high-value assets. Our model integrates rigorous asset selection, bespoke translational strategies, and efficient clinical execution. With the backing of CBC Group, we leverage deep local insights and global capabilities to develop the most promising drug candidates across a range of therapeutic categories.

The Company will utilize a “hub-and-spoke” model to create and advance specialized subsidiary companies (spokes) which maintain operational focus and agility. By focusing each spoke on a specific asset or therapeutic area, the Company can optimally manage risk and create value through potential partnering transactions.

Pipeline:

  • Givastomig, a potential best-in-class Claudin 18.2 X 4-1BB bispecific antibody, is in Phase 1b clinical trials for the potential treatment of gastric cancer and other Claudin 18.2-positive gastrointestinal malignancies. A global, randomized Phase 2 study is planned, with the enrollment of the first patient targeted in Q1 2026. Givastomig is being jointly developed through a global partnership with ABL Bio, in which NovaBridge is the lead party and shares worldwide rights, excluding Greater China and South Korea, equally with ABL Bio.
  • Ragistomig is an anti-PD-L1 X 4-1BB bispecific antibody. Built on Phase 1 clinical data, an ongoing Phase 1b study designed to expand the therapeutic index is expected to yield results in 2H 2026. The program is being jointly developed with ABL Bio.
  • Uliledlimab targets CD73, the rate-limiting enzyme critical for adenosine-driven immunosuppression in the tumor microenvironment.  Progression free survival (PFS) data are expected in 2H 2026 from an ongoing randomized Phase 2 trial evaluating uliledlimab + toripalimab compared to pembrolizumab alone or toripalimab alone in a CD73 selected population. NovaBridge owns worldwide rights to uliledlimab outside of Greater China.

VIS-101, acquired by Visara, a newly formed NovaBridge subsidiary, under the new business model, is a bifunctional biologic targeting VEGF-A and ANG2, currently in Phase 2 development

  • VIS-101 is a novel bifunctional biologic targeting VEGF-A and ANG-2, and a more potent molecule that could potentially provide more durable treatment benefits for patients with wet AMD, DME, and retinal vein occlusion (RVO) than current standard of care. VIS-101 has completed initial safety and dose-escalation studies in both the US and China, and is currently completing a randomized, dose-ranging Phase 2 study in China. VIS-101 is anticipated to be Phase 3-ready in 2026.
  • Acquisition completed by a newly formed subsidiary, Visara. Visara, a clinical-stage biopharmaceutical company focusing on the development of best-in-class ophthalmic therapeutics, was launched with an approximately $37M capital infusion from NovaBridge and the contribution of certain rights by a strategic partner.  NovaBridge is the majority shareholder of Visara, and Visara controls global rights to VIS-101.
  • Visara is led by Co-Founder and Executive Chairman Emmett T. Cunningham, Jr., MD, PhD, MPH. Dr. Cunningham has been a physician, innovator, entrepreneur, and investor for more than 25 years, formerly serving as Senior Managing Director at Blackstone Group L.P. and Managing Director at Clarus Ventures, LLC. Dr. Cunningham is also an internationally recognized specialist in infectious and inflammatory eye disease with over 450 co-authored publications.

1. The AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics is also known as the Triple Meeting, held in Boston, Massachusetts October 22-26, 2025

About NovaBridge

NovaBridge (formerly I-MAB) (Nasdaq: IMAB, to be changed to “NBP” effective October 30, 2025) is a global biotechnology platform company committed to accelerating access to innovative medicines. We combine deep business development expertise with agile translational clinical development to identify, accelerate, and advance breakthrough assets. By bridging science, strategy, and execution, NovaBridge enables transformative therapies to progress rapidly from discovery toward patients in need.

The Company’s differentiated pipeline is led by givastomig, a potential best-in-class, bispecific antibody (Claudin 18.2 x 4-1BB), and VIS-101, a second-in-class, potentially best-in-class bifunctional biologic, targeting VEGF-A and ANG2.

Givastomig conditionally activates T cells via the 4-1BB signaling pathway in the tumor microenvironment where Claudin 18.2 is expressed. Givastomig is being developed to treat Claudin 18.2-positive gastric cancer and other gastrointestinal malignancies. The Company is also collaborating with its partner, ABL Bio, for the development of ragistomig, a bispecific antibody integrating PD-L1 as a tumor engager and 4-1BB as a conditional T cell activator, in solid tumors. Additionally, NovaBridge owns worldwide rights outside of China to uliledlimab, an anti-CD73 antibody that targets adenosine-driven immunosuppression in cancer.

VIS-101 targets VEGF-A and ANG-2 to provide more potent and durable treatment benefits for patients with wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME). VIS-101 is currently completing a large, randomized, dose-ranging Phase 2 study for wet AMD. NovaBridge is the majority shareholder of Visara, and Visara controls global rights to VIS-101.

For more information, please visit https://www.novabridge.com and follow us on LinkedIn.

Company Seeking Dual Listing on Nasdaq and Hong Kong Stock Exchange

More information on NovaBridge’s intention to pursue an IPO in Hong Kong and seek a listing on the Hong Kong Stock Exchange (HKEX) will be forthcoming.

The timing, size, structure, and specific terms of the Proposed Offering have not been determined and remain subject to market conditions and approvals by the relevant regulatory authorities, including the HKEX (and the Listing Committee) and any other applicable regulatory bodies. There can be no assurance as to whether, when, or on what terms the Proposed Hong Kong Listing will be completed.

Subject to regulatory and corporate approvals, the Company currently expects to maintain its existing listing of ADSs on Nasdaq and to pursue a dual listing in the US and Hong Kong. Final decisions will be made in light of market conditions and regulatory feedback.

This announcement is for information purposes only and does not constitute, or form part of, any invitation or offer to acquire, purchase or subscribe to any securities of the Company. Shareholders and potential investors should exercise caution when dealing in the securities of the Company.

Forward Looking Statements

This announcement contains forward-looking statements. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will”, “expects”, “believes”, “designed to”, “anticipates”, “future”, “intends”, “plans”, “potential”, “estimates”, “confident”, and similar terms or the negative thereof. NovaBridge may also make written or oral forward-looking statements in its periodic reports to the U.S. Securities and Exchange Commission (the “SEC”), in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Statements that are not historical facts, including statements about the Company’s beliefs and expectations, are forward-looking statements. Forward-looking statements in this press release include, without limitation, statements regarding: the potential benefits of the new corporate strategy; the effectiveness of trading under the Company’s new name and ticker on Nasdaq; NovaBridge’s intention to pursue a Hong Kong IPO, resulting in a proposed dual listing on the Nasdaq Global Market and Hong Kong Stock Exchange (HKEX); the strategy, clinical development, plans, results, safety and efficacy of givastomig and VIS-101 and its other drug candidates; the strategic and clinical development of NovaBridge’s drug candidates, including givastomig and VIS-101; anticipated clinical milestones and results, and related timing; and the Company’s anticipated cash runway. Forward-looking statements involve inherent risks and uncertainties that may cause actual results to differ materially from those contained in these forward-looking statements, including but not limited to the following: the Company’s ability to demonstrate the safety and efficacy of its drug candidates; the Company’s ability to obtain requisite approvals from securities regulators and exchanges; the clinical results for its drug candidates, which may or may not support further development or New Drug Application/Biologics License Application (NDA/BLA) approval; the content and timing of decisions made by the relevant regulatory authorities regarding regulatory approval of the Company’s drug candidates; the Company’s ability to achieve commercial success for its drug candidates, if approved; the Company’s ability to obtain and maintain protection of intellectual property for its technology and drugs; the Company’s reliance on third parties to conduct drug development, manufacturing and other services; the Company’s limited operating history and the Company’s ability to obtain additional funding for operations and to complete the development and commercialization of its drug candidates; and those risks more fully discussed in the “Risk Factors” section in the Company’s annual report on Form 20-F filed with the SEC on April 3, 2025 as well as the discussions of potential risks, uncertainties, and other important factors in the Company’s subsequent filings with the SEC. All forward-looking statements are based on information currently available to the Company. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as may be required by law.

NovaBridge Investor & Media Contacts

PJ Kelleher

 Kyler Lei

LifeSci Advisors

 NovaBridge

+1-617-430-7579

 +1-240-745-6330

pkelleher@lifesciadvisors.com 

 kyler.lei@imabbio.com 

 IR@imabbio.com 

 

 

VIOMI Launches New AI Water Purifier “inno” in Malaysia, Appoints Shila Amzah as Brand Ambassador


KUALA LUMPUR, MALAYSIA – Media OutReach Newswire – 29 October 2025 – VIOMI, a leading global brand specializing in AI-driven water purification technology, officially launched its latest countertop AI water purifier, “inno”, in Malaysia. The launch event featured Malaysia’s renowned singer Shila Amzah, who was recently appointed as VIOMI’s Brand Ambassador. Shila attended the event in person, joining distinguished guests and media representatives to witness the debut of this innovative product that blends healthy hydration with intelligent technology.

VIOMI Launches New AI Water Purifier “inno” in Malaysia, Appoints Shila Amzah as Brand Ambassador

Mr. Chen Xiaoping, Founder and CEO of VIOMI Technology, shared during his speech: “VIOMI is a NASDAQ-listed enterprise dedicated to advancing AI water purification technology. We are thrilled to introduce our latest innovation to Malaysia — a market we view as a vital part of our global expansion strategy.”

Addressing Malaysia’s Water Quality Challenges

Malaysia continues to face significant challenges related to heavy metal contamination and microplastic pollution. In response, VIOMI developed inno, a high-performance AI water purifier specifically designed for local water conditions. With enhanced filtration precision and intelligent adaptability, inno aims to provide Malaysian households with a safer, smarter, and more enjoyable drinking water experience.

A New Standard for Healthy Drinking Water

Equipped with advanced multi-stage filtration and AI-powered remineralization, inno not only removes harmful impurities but also infuses water with strontium — a beneficial mineral known for improving calcium absorption and supporting bone, teeth, and cardiovascular health.

The result is naturally smoother, sweeter-tasting water, making inno an ideal choice for families, including children and the elderly.

Elegant, Space-Saving Design

Designed for modern homes, inno features an ultra-slim, tankless body just 13cm thick, saving valuable countertop space while maintaining a sleek and minimalist aesthetic. It seamlessly fits into various interior styles, combining beauty, practicality, and convenience.

Smart Control at Your Fingertips

Through the VIOMI Smart App, users can easily monitor real-time water quality, filter lifespan, and temperature settings. The app also supports remote cooling activation and precise temperature control (adjustable by 1°C or 5°C), ideal for different usage scenarios such as making tea, coffee, or baby formula.

With UV sterilization and 6-stage precision filtration, inno ensures every drop is clean, mineral-balanced, and safe to drink.

Eco-Friendly and Economical

Inno delivers up to 3,600 liters of purified water, equivalent to reducing the use of over 7,000 plastic bottles. The filter replacement process is designed for user convenience — tool-free, quick, and easy, allowing for long-lasting performance and sustainability.

Shila Amzah: A Voice for Health and Style

At the event, Shila Amzah shared her enthusiasm for the partnership: “I’m delighted to represent VIOMI and to introduce a smart water purifier that truly cares about family health. Inno not only looks stylish, but also transforms our daily hydration into a healthier and more enjoyable experience.”

The VIOMI AI Water Purifier “inno” is now officially available in the Malaysian market. Consumers can enjoy a two-year warranty, along with free delivery and installation services.

For more information, please visit: https://sourl.cn/MUJrDs

Hashtag: #VIOMI

The issuer is solely responsible for the content of this announcement.

ROYAL CARIBBEAN SETS THE TONE FOR SUMMER 2027 WITH EUROPEAN GETAWAYS AND A NEW BEACH CLUB

Families can explore the best of Europe with new experiences and iconic favorites, including Royal Beach Club Santorini and the bold return of Legend of the Seas 

MIAMI, Oct. 29, 2025 /PRNewswire/ — The summer of a lifetime is heating up as Royal Caribbean has revealed its bold new lineup of European holidays for the 2027 season. Kicking off the adventures is the new Royal Beach Club Santorini that will combine the breathtaking beaches of the iconic Greek island with Royal Caribbean’s signature experiences. Plus, Legend of the Seas will return to Europe offering a lineup of unforgettable 7-night adventures for every member of the family, visiting bucket-worthy destinations throughout the Mediterranean. Bookings for the European 2027 season are now open for Crown & Anchor Society members on the Royal Caribbean website ahead of the official opening on Thursday, Oct. 30.

From the history-rich coastlines of the Mediterranean to the natural wonders of Northern Europe, holidaymakers can choose from a mix of short getaways and longer adventures ranging 2-to 9- nights from Barcelona, Spain; Rome (Civitavecchia) and Ravenna, Italy; Athens (Piraeus), Greece; and Southampton, England. Returning favorites and firsts round out the season – including Mariner of the Seas making its Southampton debut and Brilliance of the Seas setting the stage in Ravenna with visits to new sun-drenched spots like Porto (Leixoes), Portugal; and Tangier, Morocco. Plus, for holidaymakers on Brilliance, Rhapsody and Odyssey of the Seas, Royal Beach Club Santorini will bring to life the ultimate beach day as part of a complete Santorini experience, combining a day of exploring the gems of the island, such as Oia and Fira, with access to the club’s stunning beaches, cabanas, authentic local cuisine and more.

The unforgettable holiday experiences continue with a combination of ways to make memories on board revolutionary ships. Families can experience a range of flavors from steakhouses to sushi and have the ultimate night out every night with jaw-dropping entertainment, live music venues, and a variety of bars and hot spots. Travelers can go all in on the action with adrenaline-pumping thrills across the fleet, such as the Crown’s Edge part skywalk, part zip line experience, The Perfect Storm water slides and the signature FlowRider surf simulator, or kick back at serene adults-only spaces, world-class spas and pools for every mood.

Europe Summer 2027 Highlights

  • Legend of the Seas – From Barcelona and Rome
    Back for another summer in the Mediterranean, Legend of the Seas will deliver 7-night Western Mediterranean holidays to destinations across France, Italy and Spain. On deck is the most dining at sea with 28 options, from the immersive Royal Railway – Legend Station taking guests on a journey through the ancient Silk Routes to the glamorous Hollywoodland Supper Club, and all-new headlining entertainment with Roald Dahl’s “Charlie and the Chocolate Factory.” Vacationers can dive into thrills like the largest waterpark at sea at Category 6 and Crown’s Edge and relax at seven pools, all with stunning ocean views.
     
  • Mariner of the Seas – From Southampton
    Vacationers can choose from a wide range of 2- to 9-night getaways, including Mariner‘s first-ever visits to Porto, where travelers can enjoy views from the Dom Luís I Bridge or tour a port wine cellar. Adventurers can set their sights on picturesque spots like the awe-inspiring Norwegian fjords, colorful buildings of Copenhagen or the famous palaces of Seville. Mariner offers something for everyone: heart-pounding fun on the Perfect Storm waterslides, fun-filled family challenges at the Royal Escape Room, and dazzling performances on ice at Studio B. Dining ranges from Jamie’s Italian and Chops Grille to classic favorites like Johnny Rockets.
     
  • Rhapsody of the Seas – from Athens (Piraeus), Greece
    Making a bold return to the Mediterranean after four years, Rhapsody of the Seas will introduce 7-night holidays across the Eastern Mediterranean to top destinations filled with rich cultures such as Tangier, Morocco; and Bodrum and Istanbul, Turkey. Travelers can also explore some of the best spots in Greece in Mykonos and Santorini, including visits to the all-new Royal Beach Club Santorini, along with overnights inIstanbul, or Alexandria, Egypt. From taking in acrobatic shows in the seven-story Centrum to scaling the rock-climbing wall or unwinding in the Solarium, holidaymakers will be wowed both on land and at sea.
     
  • Brilliance of the Seas – From Ravenna
    Brilliance of the Seas will explore the best of the Mediterranean on 7-night adventures to the breathtaking Greek Isles, Croatia and the Adriatic coast. Vacationers can discover Royal Beach Club Santorini in Greece; stroll the seaside promenades of Split, Croatia; or journey through Montenegro’s fjords. On deck, guests can marvel at the nine-story glass-encased Centrum, savor flavors from Chops Grille steakhouse to Izumi’s Asian cuisine and enjoy a drink at R Bar or a glass of wine at Vintages.
     
  • Explorer of the Seas – From Barcelona, Rome, Ravenna and Athens 
    Returning to the Mediterranean, Explorer of the Seas will offer 7-night journeys across Italy, France, Spain, Croatia, Montenegro and the Greek Isles. Adventurers can wander Dubrovnik’s Old Town, discover the charm of Provence or explore the ancient history of Athens and the Acropolis. The thrills continue on board with the FlowRider surf simulator, rock-climbing wall, and ice-skating rink, along with nine pools and whirlpools. Ways to dine include Giovanni’s Table, Izumi, and the ever-popular Windjammer. Evenings sparkle with stage shows at the Palace Theatre and live music in the Schooner Bar.
     
  • Odyssey of the Seas – From Rome
    Welcoming back another summer in Europe, Odyssey of the Seas will feature 7-night Greek Isles vacations to Mykonos and Santorini – including Royal Beach Club Santorini – Ephesus (Kusadasi), Turkey; and Naples, Italy. From sun-drenched beaches to ancient ruins, guests can immerse themselves in centuries of history and culture. Thrill-seekers have adventures on board like the North Star observation pod, and SeaPlex, featuring bumper cars and laser tag. With diverse global dining options and high-tech entertainment at Two70, Odyssey turns every meal and every moment into an unforgettable memory.

Holidaymakers can learn more about new and upcoming European adventures by visiting Royal Caribbean’s website.

About Royal Caribbean 

Royal Caribbean, part of Royal Caribbean Group (NYSE: RCL), has delivered memorable vacations for more than 50 years. The cruise line’s game-changing ships and exclusive destinations revolutionize vacations with innovations and an all-encompassing combination of experiences, from thrills to dining and entertainment, for every type of family and vacationer. Voted “Best Cruise Line Overall” for 22 consecutive years in the Travel Weekly Readers Choice Awards, Royal Caribbean makes memories with adventurers across more than 300 destinations in 80 countries on all seven continents, including the line’s top-rated exclusive destination, Perfect Day at CocoCay in The Bahamas.   

Media can stay up to date by following @RoyalCaribPR on X and visit www.RoyalCaribbeanPressCenter.com. For additional information or to book, vacationers can visit www.RoyalCaribbean.com, call (800) ROYAL-CARIBBEAN or contact their travel advisor.  

Royal Beach Club Santorini will welcome vacationers from Royal Caribbean and combine the breathtaking volcanic beaches of this iconic Greek island with the company’s signature experiences alongside the vibrant Grecian spirit and culture to create the ultimate Santorini experience. The beach club will be part of an Ultimate Santorini Day that will include a day of exploring the gems of the island at Oia and Fira.
Royal Beach Club Santorini will welcome vacationers from Royal Caribbean and combine the breathtaking volcanic beaches of this iconic Greek island with the company’s signature experiences alongside the vibrant Grecian spirit and culture to create the ultimate Santorini experience. The beach club will be part of an Ultimate Santorini Day that will include a day of exploring the gems of the island at Oia and Fira.

 

Royal Caribbean’s Legend of the Seas is the newest family vacation set to deliver summer 2026 adventures to Europe ahead of its grand Caribbean debut from Fort Lauderdale, Florida, in November 2026. Vacationers can go all in on bold experiences like the most dining at sea with 28 options, new entertainment and more ways to thrill, chill and stay.
Royal Caribbean’s Legend of the Seas is the newest family vacation set to deliver summer 2026 adventures to Europe ahead of its grand Caribbean debut from Fort Lauderdale, Florida, in November 2026. Vacationers can go all in on bold experiences like the most dining at sea with 28 options, new entertainment and more ways to thrill, chill and stay.

 

Video – https://www.youtube.com/watch?v=s4CGJc-lCdw

Armada Acquisition Corp. II Announces Ticker Symbol to Change to XRPN on Oct 30, 2025

New ticker aligns with new $1 billion strategy for XRP exposure on NASDAQ

MIAMI, Oct. 29, 2025 /PRNewswire/ — Armada Acquisition Corp. II, a special purpose acquisition company (“Armada II”) sponsored by Arrington XRP Capital Fund, today announced that it will change the  ticker symbol for its Class A ordinary shares on NASDAQ from “AACI” to  “XRPN.” In addition, the ticker symbol for its units will change from “AACIU” to “XRPNU” and the ticker symbol for its warrants will change from “AACIW” to “XRPNW.” The ticker symbol changes will be effective upon the commencement of trading on NASDAQ on October 30, 2025. Representing a key milestone in the company’s strategic transformation, this change underscores the company’s evolution into the world’s leading institutional XRP digital asset treasury company.

The ticker symbol changes come on the heels of last week’s announcement that Evernorth Holdings, Inc., a newly formed Nevada corporation (“Evernorth”), has executed a business combination agreement with Armada II (the “Business Combination Agreement”) which will result in a new company that has raised over $1 billion in gross proceeds to fund open-market purchases of XRP.

“As the SPAC sponsor and longtime XRP fanatics, we at Arrington Capital have high conviction in Evernorth’s ability to drive meaningful impact and add shareholder value,” said Michael Arrington, founder of Arrington Capital & Chairman of the Board at Armada Acquisition Corp. II. “In recent months, XRP has maintained its prominence in an ecosystem that continues to expand through bold product innovations, a relentless community and a string of notable new contributors – including Hidden Road, GTreasury, Rail and Standard Custody.”

For more information on Evernorth, visit www.evernorth.xyz.

About Evernorth
At closing of a newly announced Business Combination Agreement with Armada II, Evernorth will be a publicly traded digital asset treasury that provides investors with exposure to XRP through a regulated, liquid, and transparent structure. Unlike ETFs, Evernorth intends to actively grow its XRP per share through a mix of institutional and DeFi yield strategies, ecosystem participation, and capital markets activities.

About Arrington Capital
Arrington Capital is a digital asset management firm primarily focused on blockchain-based capital markets. The firm, co-founded in 2017 by TechCrunch and CrunchBase founder Michael Arrington, has invested in hundreds of startups around the world. Arrington Capital is a seasoned, international team composed of Silicon Valley veterans and operators with deep venture capital experience and crypto native roots. Arrington XRP Capital Fund, LP is the SPAC sponsor for Armada Acquisition Corp II  Additionally, Rippleworks’ investment in this PIPE transaction will be done through the Arrington XRP Capital Fund, LP.

About Armada Acquisition Corp. II (Nasdaq: XRPN)
Armada II is a special purpose acquisition company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses. Armada II was founded on October 3, 2024.

Additional Information and Where to Find It

Armada II and Evernorth intend to file with the Securities and Exchange Commission (the “SEC”) a Registration Statement on Form S-4 (as may be amended, the “Registration Statement”), which will include a preliminary proxy statement of Armada II and a prospectus of Evernorth (the “Proxy Statement/Prospectus”) in connection with the proposed business combination (the “Business Combination”), certain private placements of securities in connection with the Business Combination (the “Private Placement Transactions”) and the other transactions contemplated by the Business Combination Agreement and/or as described in this press release (together with the Business Combination and the Private Placement Transactions, the “Proposed Transactions”). The definitive proxy statement and other relevant documents will be mailed to shareholders of Armada II as of the record date to be established for voting on the Business Combination and other matters as described in the Proxy Statement/Prospectus. Armada II and/or Evernorth will also file other documents regarding the Proposed Transactions with the SEC. This press release does not contain all of the information that should be considered concerning the Proposed Transactions and is not intended to form the basis of any investment decision or any other decision in respect of the Proposed Transactions. BEFORE MAKING ANY VOTING OR INVESTMENT DECISION, SHAREHOLDERS OF ARMADA II AND OTHER INTERESTED PARTIES ARE URGED TO READ, WHEN AVAILABLE, THE PRELIMINARY PROXY STATEMENT/PROSPECTUS, AND AMENDMENTS THERETO, AND THE DEFINITIVE PROXY STATEMENT/PROSPECTUS AND ALL OTHER RELEVANT DOCUMENTS FILED OR THAT WILL BE FILED WITH THE SEC IN CONNECTION WITH ARMADA II’S SOLICITATION OF PROXIES FOR THE EXTRAORDINARY GENERAL MEETING OF ITS SHAREHOLDERS TO BE HELD TO APPROVE THE PROPOSED TRANSACTIONS AND OTHER MATTERS AS DESCRIBED IN THE PROXY STATEMENT/PROSPECTUS BECAUSE THESE DOCUMENTS WILL CONTAIN IMPORTANT INFORMATION ABOUT ARMADA II, PATHFINDER DIGITAL ASSETS LLC, EVERNORTH AND THE PROPOSED TRANSACTIONS. Investors and security holders will also be able to obtain copies of the Registration Statement and the Proxy Statement/Prospectus and all other documents filed or to be filed with the SEC by Armada II and Evernorth, without charge, once available, on the SEC’s website at www.sec.gov, or by directing a request to: Armada Acquisition Corp. II, 382 NE 191st St., Suite 52895, Miami, Florida 33179-52895; e-mail: finance@arringtoncapital.com, or to: Evernorth Holdings Inc., 600 Battery St, San Francisco, CA 94111, email: finance@evernorth.xyz.

NEITHER THE SEC NOR ANY STATE SECURITIES REGULATORY AGENCY HAS APPROVED OR DISAPPROVED THE PROPOSED TRANSACTIONS DESCRIBED HEREIN, PASSED UPON THE MERITS OR FAIRNESS OF THE BUSINESS COMBINATION, OR ANY RELATED TRANSACTIONS OR PASSED UPON THE ADEQUACY OR ACCURACY OF THE DISCLOSURE IN THIS PRESS RELEASE. ANY REPRESENTATION TO THE CONTRARY CONSTITUTES A CRIMINAL OFFENSE.

The securities to be issued by Evernorth and the units to be issued by Pathfinder Digital Assets LLC (“Pathfinder”), in each case, in connection with the Proposed Transactions, have not been registered under the Securities Act of 1933, as amended (the “Securities Act”) and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Securities Act.

Participants in the Solicitation

Armada II, Evernorth, Pathfinder and their respective directors and executive officers may be deemed under SEC rules to be participants in the solicitation of proxies from Armada II shareholders in connection with the Business Combination. A list of the names of such directors and executive officers, and information regarding their interests in the Business Combination and their ownership of Armada II’s securities is, or will be, contained in Armada II’s filings with the SEC. Additional information regarding the interests of the persons who may, under SEC rules, be deemed participants in the solicitation of proxies from Armada II shareholders in connection with the Business Combination, including the names and interests of Pathfinder and Evernorth’s directors and executive officers, will be set forth in the Proxy Statement/Prospectus, which is expected to be filed by Armada II and Evernorth with the SEC. Investors and security holders may obtain free copies of these documents as described above.

No Offer or Solicitation

This press release is for informational purposes only and is not a proxy statement or solicitation of a proxy, consent or authorization, with respect to any securities or in respect of the Proposed Transactions and shall not constitute an offer to sell or exchange, or a solicitation of an offer to buy or exchange the securities of Armada II, Pathfinder or Evernorth, or any commodity or instrument or related derivative, nor shall there be any sale of any such securities in any state or jurisdiction in which such offer, solicitation, sale or exchange would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of the Securities Act or an exemption therefrom. Investors should consult with their counsel as to the applicable requirements for a purchaser to avail itself of any exemption under the Securities Act.

Forward-Looking Statements

This press release contains certain forward-looking statements within the meaning of the U.S. federal securities laws with respect to the Proposed Transactions and the parties thereto. All statements contained in this press release other than statements of historical fact, including, without limitation, statements regarding the effective date of the ticker symbol changes; statements regarding the Business Combination between Armada II and Evernorth; the anticipated benefits and timing of the transaction; expected trading of the combined company’s securities on Nasdaq; the completion of investments from certain institutional investors; the expected amount of gross proceeds from investments; the anticipated use of proceeds from such investments; the evolution of the company into, and the building of the world’s leading institutional XRP treasury; the amount of XRP expected to be held by the combined company; the combined company’s future financial performance, the ability of the combined company to execute its business strategy, its market opportunity and positioning; expectations regarding institutional and retail adoption of XRP and participation in DeFi yield strategies; the combined company’s contributions to the growth and maturity of the ecosystem, using an approach designed to generate returns for shareholders, supporting XRP’s utility and adoption, alignment with the growth of the XRP ecosystem, and becoming the leading institutional vehicle for XRP; management ensuring operational independence, taking XRP’s presence in capital markets to the next level, and other statements regarding management’s intentions, beliefs, or expectations with respect to the combined company’s future performance, are forward-looking statements.

Forward-looking statements are often identified by the use of words such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “potential,” “predict,” “project,” “should,” “will,” “would,” and similar expressions, but the absence of these words does not mean that a statement is not forward-looking.

These forward-looking statements are based on the current expectations and assumptions of Armada II and Evernorth and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, but are not limited to: (1) the occurrence of any event, change or other circumstances that could delay or prevent the consummation of the proposed Business Combination; (2) the outcome of any legal proceedings that may be instituted against Armada II, Evernorth, the combined company, or others following the announcement of the Proposed Transactions; (3) the inability to complete the Business Combination due to failure to obtain shareholder approval or satisfy other closing conditions; (4) the inability to complete the Private Placement Transactions, (5) changes to the structure, timing, or terms of the Proposed Transactions; (6) the ability of the combined company to meet applicable listing standards or to maintain the listing of its securities following the closing of the Business Combination; (7) the risk that the announcement and consummation of the transaction disrupts current plans and operations; (8) the ability to recognize the anticipated benefits of the Business Combination, including the ability to build and manage an institutional XRP treasury, execute DeFi yield strategies, and drive institutional adoption of XRP; (9) changes in market, regulatory, political, and economic conditions affecting digital assets generally or XRP specifically; (10) the costs related to the Proposed Transactions and those arising as a result of becoming a public company; (11) the level of redemptions of Armada II’s public shareholders which may reduce the public float of, reduce the liquidity of the trading market of, and/or maintain the quotation, listing, or trading of securities of Armada II or of Evernorth; (12) the volatility of the price of XRP and other digital assets, the correlation between XRP’s price and the value of Evernorth’s securities, and the risk that the price of XRP may decrease between the signing of the definitive documents for the Proposed Transactions and the closing of the Proposed Transactions or at any time after the closing of the Proposed Transactions; (13) risks related to increased competition in the industries in which Evernorth will operate; (14) risks related to changes in U.S. or foreign laws and regulations applicable to digital assets or securities; (15) the possibility that the combined company may be adversely affected by competitive factors, investor sentiment, or other macroeconomic conditions; (16) the risk of being considered to be a “shell company” by any stock exchange on which Evernorth securities will be listed or by the SEC, which may impact the ability to list Evernorth’s securities and restrict reliance on certain rules or forms in connection with the offering, sale or resale of securities; (17) the outcome of any potential legal proceedings that may be instituted against the Pathfinder, Armada II, Evernorth or others following announcement of the Business Combination; and (18) other risks detailed from time to time in Armada II’s filings with the SEC, including the Registration Statement and related documents filed or to be filed in connection with the Business Combination.

The foregoing list of risk factors is not exhaustive. You should carefully consider the foregoing factors and the other risks and uncertainties described in the “Risk Factors” section of the final prospectus of Armada II dated May 20, 2025 and filed by Armada II with the SEC on May 21, 2025, Armada II’s Quarterly Report on Form 10-Q filed with the SEC on August 11, 2025, and the Registration Statement and Proxy Statement/Prospectus that will be filed by Evernorth and Armada II, and other documents filed by Armada II and Evernorth from time to time with the SEC, as well as the list of risk factors included herein. These filings do or will identify and address other important risks and uncertainties that could cause actual results to differ materially from those contained in the forward-looking statements. Additional risks and uncertainties not currently known or that are currently deemed immaterial may also cause actual results to differ materially from those expressed or implied by such forward-looking statements. Readers are cautioned not to put undue reliance on forward-looking statements, and none of the parties or any of their representatives assumes any obligation and do not intend to update or revise these forward-looking statements, each of which is made only as of the date of this press release.

JETOUR T1 i-DM Hits the Philippines, Leading Smart Hybrid Trend

MANILA, Philippines, Oct. 29, 2025 /PRNewswire/ — JETOUR officially launched the T1 i-DM in the Philippines. As the hybrid version of the T1, the vehicle continues the series’ signature “New Rugged” design philosophy, setting a new trend in SUV. Positioned as a “PHEV Urban SUV”, it is designed to meet the diverse needs of local users, from daily city commutes to weekend adventures, aiming to deliver a comprehensive and innovative mobility experience for all scenarios.


Under the theme ‘Future Meets the Past’, the launch event showcased a fusion of Filipino cultural heritage and cutting-edge technology. Against a backdrop of traditional dance and modern music, the JETOUR T1 i-DM was unveiled. An immersive VR experience zone, “Drive Through the Philippines,” allowed guests to virtually navigate the country’s iconic landmarks. It also offered a preview of the T1 i-DM’s intelligent driving performance.

T1 i-DM features highly distinctive four-leaf clover headlights and a full-width horizon light bar. Inside, the cabin strikes a deliberate balance between robust capability and refined comfort, achieved through meticulous craftsmanship, elegant stitching, fluid contours, and extensive use of soft-touch materials.

At the launch event, Mr. Ke Chuandeng, President of JETOUR International, stated: “The hybrid system in the T1 i-DM directly responds to users’ dual expectations for low fuel consumption and an EV-like driving experience, making it an ideal choice that balances daily commutes with weekend journeys.”

The model is powered by a dedicated hybrid powertrain with an industry-leading 44.5% thermal efficiency engine. Coupled with a hybrid-specific transmission, the T1 i-DM achieves an impressive fuel consumption of just 1.08L/100 km, while maintaining as low as 5.89L/100 km even in low-charge conditions. Furthermore, during the vast majority of daily driving scenarios, the T1 i-DM operates in pure electric mode, delivering a smooth and quiet ride experience that is nearly indistinguishable from a full EV.

With the launch of the T1 i-DM, JETOUR marks a significant step forward for JETOUR in its new energy strategy. Moving forward, JETOUR will continue to deepen its hybrid technology portfolio and introduce more innovative products to accelerate the transition to green mobility. The brand aims to become “The World’s Leading Hybrid Off-road SUV Brand.”

Parcel Perform Defines ‘GEO’ for E-Commerce with Launch of AI Commerce Visibility

Brands can now track, analyze and optimize their visibility across AI shopping agents like ChatGPT, Perplexity, and Gemini.

SINGAPORE, CHICAGO and BERLIN, Oct. 29, 2025 /PRNewswire/ — AI shopping agents are reshaping how consumers discover and buy products—creating a new mandate for e-commerce brands. Today, Parcel Perform, the leading Delivery Experience Platform, unveiled the enterprise beta of AI Commerce Visibility under the slogan “Found by AI, Chosen by Shoppers.” It is the first solution built for e-commerce businesses to monitor, analyze and improve visibility across AI shopping platforms.

AI Commerce Visibility is the first platform to bridge brand visibility directly to operational performance. When a shopper asks, “What’s the best online store for running shoes in NYC?”, the AI’s answer isn’t just based on keywords and product descriptions. It also analyzes real-world data like delivery speed and return policies to find the “best” brand. This is the new discipline of Generative Engine Optimization (GEO)—and unlike SEO, it’s won by proving real-world performance.

“The shift to AI-driven discovery is happening faster than anyone predicted. 39% of consumers now use AI for product exploration. The biggest risk for brands is now no longer a bad ad campaign—it’s complete invisibility,” said Dr. Arne Jeroschewski, CEO and Co-Founder of Parcel Perform.

He added, “There is more to visibility than doubling down on the old SEO playbook and playing a volume game. The era of AI Commerce will be won on operational performance, not marketing promises. Brands that understand how AI assesses their product offering today will dominate AI commerce tomorrow. We are launching AI Commerce Visibility in beta today to partner with leading brands on this challenge, and it is our mission to give every brand the power to prove their operational excellence, ensuring they are not just found by AI, but are ultimately the first and best choice for shoppers.”

How AI Shopping Agents Evaluate E-Commerce Brands

AI Commerce Visibility answers the critical question: “How do AI agents recommend brands, products, and channels?” Four capabilities are the key to achieve the goals of brands around AI visibility:

  • Focus: AI Commerce Lens Provides a complete, 360-degree view of your brand’s AI Commerce presence. It analyzes the four critical dimensions—Brand Visibility, Product Dominance, Channel Attribution, and AI Trust Signals—that determine whether AI agents recommend your brand or steer shoppers to competitors.
  • Monitor: Decode AI Presence Reveals visibility gaps across all major AI platforms: ChatGPT, Perplexity, Gemini, Google AI Overviews, Claude, Microsoft Copilot, DeepSeek, and Grok. It tracks the high-intent e-commerce prompts that drive purchases and monitors performance by country, market, and language.
  • Insights: Benchmark Competitors Instantly compare your AI share of voice against competitors with a comprehensive AI Visibility Score. The platform tracks ranking changes to strategically capture high-value recommendations and diagnoses AI sentiment, pinpointing negative trends before they erode consumer trust.
  • Action: Fix AI Commerce Presence Move from passive monitoring to active optimization with a prioritized action plan. The platform analyzes the sources AI agents trust most, delivering custom recommendations to improve product listings, webstore structure, and operational trust signals, turning your brand into an AI-preferred choice.

AI Commerce Visibility is a new solution from Parcel Perform, designed to get a brand found by AI. This powerful new capability works in tandem with the rest of the Parcel Perform platform—which includes Post-Purchase Experience, Checkout Experience, Logistics Experience, and Returns Experience—to ensure that brands are consistently chosen by shoppers. Enterprise and mid-market retailers interested in AI Commerce Visibility can request access to Parcel Perform’s beta at www.parcelperform.com.

About Parcel Perform

Parcel Perform (www.parcelperform.com) is the leading AI Delivery Experience Platform, enabling brands to thrive in the age of AI Commerce by connecting AI Visibility with operational excellence and customer retention. Built on the industry’s most comprehensive logistics data—tracking over 1,100+ carriers, 155+ event types, and 36+ languages—the platform offers a full suite of solutions: AI Commerce Visibility, Checkout Experience, Post-Purchase Experience, Returns Experience, and Logistics Experience. All solutions are powered by the company’s central intelligence layer, AI Decision Intelligence, with the new AI Commerce Visibility solution connecting a brand’s visibility across AI shopping agents to its actual delivery performance.

Delta to Acquire Noda RF Technologies Co., Ltd. to Enhance its Power Solutions Portfolio for the Semiconductor Industry

TAIPEI, Oct. 29, 2025 /PRNewswire/ — Delta Electronics, Inc. (“Delta”), a leader in power management and smart green solutions, today announced the acquisition of 90.23% stake of Japan’s Noda RF Technologies Co., Ltd. (“NRF”) through its subsidiary Delta Electronics (Netherlands) B.V. for JPY 5,024 million (approximately NT$1,034 million). Combined with its existing stake, Delta will hold 100% ownership of NRF upon completion of the transaction (*). NRF provides critical radio frequency (RF) power supply systems for core semiconductor manufacturing processes, playing a vital role in semiconductor manufacturing quality, chip yield, and precision. This transaction is expected to strengthen Delta’s comprehensive power solutions for key semiconductor manufacturing equipment providers.

Ping Cheng, Delta’s Chairman and CEO, said, “Semiconductors are the cornerstone driving technological advancement. As a global leader in power management, Delta also provides superior energy efficiency power solutions for semiconductor equipment. NRF is an expert in RF power supplies, complementing Delta’s technology. The successful collaboration between the two companies in the past has laid a strong foundation for future seamless integration. We believe that with NRF, Delta will be able to reinforce its solutions portfolio and create greater synergies in R&D, business opportunities, and support to global semiconductor equipment customers.

Kazutoshi Noda, CEO of Noda RF Technologies Co., Ltd., said, “NRF is committed to advancing RF system. Our products play an indispensable role in semiconductor equipment and driving industrial digitalization. With our outstanding R&D capabilities and engineering support, NRF has long served frontline customers in Japan and earned high acclaim. We are delighted to join Delta and look forward to leveraging Delta’s global footprint, manufacturing capabilities, and business strengths to create greater value for semiconductor applications.”

Noda RF Technologies Co., Ltd., established in 2002 and headquartered in Osaka, Japan, specializes in manufacturing RF system for semiconductor manufacturing equipment. These systems are applied in processes such as etching, CVD (Chemical Vapor Deposition), and PVD (Physical Vapor Deposition). The company’s R&D products are critical to wafer yield and process precision. Beyond the semiconductor sector, NRF’s solutions extend to other industries including LCD panel manufacturing. The company’s domain knowledge, technical proficiency, and customization capabilities have earned widespread recognition within the sector.

* Note: The closing of the transaction is subject to satisfaction of certain closing conditions (such as regulatory approvals).

About Delta 
Delta, founded in 1971, and listed on the Taiwan Stock Exchange (code:2308), is a global leader in switching power supplies and thermal management products with a thriving portfolio of IoT-based smart energy-saving systems and solutions in the fields of industrial automation, building automation, telecom power, data center infrastructure, EV charging, renewable energy, energy storage and display, to nurture the development of smart manufacturing and sustainable cities. As a world-class corporate citizen guided by its mission statement, “To provide innovative, clean and energy-efficient solutions for a better tomorrow,” Delta leverages its core competence in high-efficiency power electronics and its ESG-embedded business model to address key environmental issues, such as climate change. Delta serves customers through its sales offices, R&D centers and manufacturing facilities spread over close to 200 locations across 5 continents.

Throughout its history, Delta has received various global awards and recognition for its business achievements, innovative technologies and dedication to ESG. Since 2011, Delta has been listed on the Dow Jones Best-in-Class World Index (formerly the DJSI World Index of Dow Jones Sustainability™ Indices) for 14 consecutive years. Delta has also won CDP with double A List for 4 times for its substantial contribution to climate change and water security issues and has been named Supplier Engagement Leader for its continuous development of a sustainable value chain for 7 consecutive years.

For detailed information about Delta, please visit: www.deltaww.com